Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts

Identifieur interne : 004A10 ( PascalFrancis/Curation ); précédent : 004A09; suivant : 004A11

Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts

Auteurs : Dedee F. Murrell [Australie] ; Benjamin S. Daniel [Australie] ; Pascal Joly [France] ; Luca Borradori [France] ; Masayuki Amagai [Japon] ; Takashi Hashimoto [Japon] ; Frederic Caux [France] ; Branka Marinovic [Serbie] ; Animesh A. Sinha [États-Unis] ; Michael Hertl [Afrique du Sud] ; Philippe Bernard ; David Sirois [États-Unis] ; Giuseppe Cianchini [Italie] ; Janet A. Fairley [États-Unis] ; Marcel F. Jonkman [Allemagne] ; Amit G. Pandya [États-Unis] ; David Rubenstein [États-Unis] ; Detlef Zillikens [États-Unis] ; Aimee S. Payne [États-Unis] ; David Woodley [États-Unis] ; Giovanna Zambruno [Italie] ; Valeria Aoki [États-Unis] ; Carlo Pincelli [États-Unis] ; Luis Diaz [États-Unis] ; Russell P. Hall [États-Unis] ; Michael Meurer [Allemagne] ; Jose M. Jr Mascaro [Espagne] ; Enno Schmidt [États-Unis] ; Hiroshi Shimizu [Japon] ; John Zone ; Robert Swerlick ; Daniel Mimouni ; Donna Culton [États-Unis] ; Jasna Lipozencic [Serbie] ; Benjamin Bince ; Sergei A. Grando ; Jean-Claude Bystryn ; Victoria P. Werth [États-Unis]

Source :

RBID : Pascal:12-0153002

Descripteurs français

English descriptors

Abstract

Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.
pA  
A01 01  1    @0 0190-9622
A02 01      @0 JAADDB
A03   1    @0 J. Am. Acad. Dermatol.
A05       @2 66
A06       @2 3
A08 01  1  ENG  @1 Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
A11 01  1    @1 MURRELL (Dedee F.)
A11 02  1    @1 DANIEL (Benjamin S.)
A11 03  1    @1 JOLY (Pascal)
A11 04  1    @1 BORRADORI (Luca)
A11 05  1    @1 AMAGAI (Masayuki)
A11 06  1    @1 HASHIMOTO (Takashi)
A11 07  1    @1 CAUX (Frederic)
A11 08  1    @1 MARINOVIC (Branka)
A11 09  1    @1 SINHA (Animesh A.)
A11 10  1    @1 HERTL (Michael)
A11 11  1    @1 BERNARD (Philippe)
A11 12  1    @1 SIROIS (David)
A11 13  1    @1 CIANCHINI (Giuseppe)
A11 14  1    @1 FAIRLEY (Janet A.)
A11 15  1    @1 JONKMAN (Marcel F.)
A11 16  1    @1 PANDYA (Amit G.)
A11 17  1    @1 RUBENSTEIN (David)
A11 18  1    @1 ZILLIKENS (Detlef)
A11 19  1    @1 PAYNE (Aimee S.)
A11 20  1    @1 WOODLEY (David)
A11 21  1    @1 ZAMBRUNO (Giovanna)
A11 22  1    @1 AOKI (Valeria)
A11 23  1    @1 PINCELLI (Carlo)
A11 24  1    @1 DIAZ (Luis)
A11 25  1    @1 HALL (Russell P.)
A11 26  1    @1 MEURER (Michael)
A11 27  1    @1 MASCARO (Jose M. JR)
A11 28  1    @1 SCHMIDT (Enno)
A11 29  1    @1 SHIMIZU (Hiroshi)
A11 30  1    @1 ZONE (John)
A11 31  1    @1 SWERLICK (Robert)
A11 32  1    @1 MIMOUNI (Daniel)
A11 33  1    @1 CULTON (Donna)
A11 34  1    @1 LIPOZENCIC (Jasna)
A11 35  1    @1 BINCE (Benjamin)
A11 36  1    @1 GRANDO (Sergei A.)
A11 37  1    @1 BYSTRYN (Jean-Claude)
A11 38  1    @1 WERTH (Victoria P.)
A14 01      @1 Department of Dermatology at St George Hospital, University of New South Wales @2 Sydney @3 AUS @Z 1 aut. @Z 2 aut.
A14 02      @1 Clinique Dermatologique, Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM U905, Rouen University Hospital, Dermatology Department, Rouen University Hospital, University of Rouen @3 FRA @Z 3 aut.
A14 03      @1 Department of Dermatology, University Hospital of Bern @3 FRA @Z 4 aut.
A14 04      @1 Keio University School of Medicine @2 Tokyo @3 JPN @Z 5 aut.
A14 05      @1 Kurume University School of Medicine @3 JPN @Z 6 aut.
A14 06      @1 Department of Dermatology, University of Paris XIII @2 Bobigny @3 FRA @Z 7 aut.
A14 07      @1 Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine @3 SRB @Z 8 aut. @Z 34 aut.
A14 08      @1 Department of Dermatology, State University of New York at Buffalo @2 Buffalo, New York @3 USA @Z 9 aut.
A14 09      @1 Department of Dermatology, University Hospital @2 Marburg @3 ZAF @Z 10 aut.
A14 10      @1 Department of Oral Medicine, New York University College of Dentistry @3 USA @Z 12 aut.
A14 11      @1 Immunodermatology Departmentand @3 ITA @Z 13 aut.
A14 12      @1 Laboratory of Molecular and Cell Biology,Instituto Dermopatico dell'Immacolata, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) IRCCS @2 Rome @3 ITA @Z 21 aut.
A14 13      @1 Departments of Dermatology, University of Iowa and Department of Veterans Affairs Medical Center Iowa City @3 USA @Z 14 aut.
A14 14      @1 University Medical Center Groningen, University of Groningen @3 DEU @Z 15 aut.
A14 15      @1 University of Texas Southwestern Medical Center @3 USA @Z 16 aut.
A14 16      @1 Department of Dermatology, University of North Carolina @2 Chapel Hill @3 USA @Z 17 aut. @Z 24 aut. @Z 33 aut.
A14 17      @1 Department of Dermatology, University of Luebeck @3 USA @Z 18 aut. @Z 28 aut.
A14 18      @1 Department of Dermatology, Keck School of Medicine, University of Southern California @3 USA @Z 20 aut.
A14 19      @1 Department of Dermatology, University of Pennsylvania @3 USA @Z 19 aut. @Z 38 aut.
A14 20      @1 Department of Dermatology, University of Sao Paulo @3 USA @Z 22 aut.
A14 21      @1 Institute of Dermatology, School of Biosciences and Biotechnologies, University of Modena and Reggio Emilia @3 USA @Z 23 aut.
A14 22      @1 Division of Dermatology, Duke Medical Center @2 Durham @3 USA @Z 25 aut.
A14 23      @1 Department of Dermatology, Hokkaido University Graduate School of Medicine @2 Sapporo @3 JPN @Z 29 aut.
A14 24      @1 Carl Gustav Carus Medical School, Dresden University of Technology" @3 DEU @Z 26 aut.
A14 25      @1 Department of Dermatology, University of Barcelona @3 ESP @Z 27 aut.
A20       @1 479-485
A21       @1 2012
A23 01      @0 ENG
A43 01      @1 INIST @2 18387 @5 354000502871510180
A44       @0 0000 @1 © 2012 INIST-CNRS. All rights reserved.
A45       @0 10 ref.
A47 01  1    @0 12-0153002
A60       @1 P
A61       @0 A
A64 01  1    @0 Journal of the American Academy of Dermatology
A66 01      @0 USA
C01 01    ENG  @0 Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.
C02 01  X    @0 002B08E
C03 01  X  FRE  @0 Pemphigoïde bulleuse @2 NM @5 01
C03 01  X  ENG  @0 Bullous pemphigoid @2 NM @5 01
C03 01  X  SPA  @0 Penfigoide buloso @2 NM @5 01
C03 02  X  FRE  @0 Définition @5 07
C03 02  X  ENG  @0 Definition @5 07
C03 02  X  SPA  @0 Definición @5 07
C03 03  X  FRE  @0 Pronostic @5 08
C03 03  X  ENG  @0 Prognosis @5 08
C03 03  X  SPA  @0 Pronóstico @5 08
C03 04  X  FRE  @0 Recommandation @5 09
C03 04  X  ENG  @0 Recommendation @5 09
C03 04  X  SPA  @0 Recomendación @5 09
C03 05  X  FRE  @0 Dermatologie @5 13
C03 05  X  ENG  @0 Dermatology @5 13
C03 05  X  SPA  @0 Dermatología @5 13
C07 01  X  FRE  @0 Dermatose bulleuse @5 37
C07 01  X  ENG  @0 Bullous dermatosis @5 37
C07 01  X  SPA  @0 Dermatosis bulosa @5 37
C07 02  X  FRE  @0 Maladie autoimmune @5 38
C07 02  X  ENG  @0 Autoimmune disease @5 38
C07 02  X  SPA  @0 Enfermedad autoinmune @5 38
C07 03  X  FRE  @0 Pathologie de la peau @5 39
C07 03  X  ENG  @0 Skin disease @5 39
C07 03  X  SPA  @0 Piel patología @5 39
C07 04  X  FRE  @0 Immunopathologie @5 40
C07 04  X  ENG  @0 Immunopathology @5 40
C07 04  X  SPA  @0 Inmunopatología @5 40
N21       @1 114
N44 01      @1 OTO
N82       @1 OTO

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:12-0153002

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts</title>
<author>
<name sortKey="Murrell, Dedee F" sort="Murrell, Dedee F" uniqKey="Murrell D" first="Dedee F." last="Murrell">Dedee F. Murrell</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Dermatology at St George Hospital, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Daniel, Benjamin S" sort="Daniel, Benjamin S" uniqKey="Daniel B" first="Benjamin S." last="Daniel">Benjamin S. Daniel</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Dermatology at St George Hospital, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Joly, Pascal" sort="Joly, Pascal" uniqKey="Joly P" first="Pascal" last="Joly">Pascal Joly</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Clinique Dermatologique, Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM U905, Rouen University Hospital, Dermatology Department, Rouen University Hospital, University of Rouen</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Borradori, Luca" sort="Borradori, Luca" uniqKey="Borradori L" first="Luca" last="Borradori">Luca Borradori</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Department of Dermatology, University Hospital of Bern</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Amagai, Masayuki" sort="Amagai, Masayuki" uniqKey="Amagai M" first="Masayuki" last="Amagai">Masayuki Amagai</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Keio University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author>
<name sortKey="Hashimoto, Takashi" sort="Hashimoto, Takashi" uniqKey="Hashimoto T" first="Takashi" last="Hashimoto">Takashi Hashimoto</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Kurume University School of Medicine</s1>
<s3>JPN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author>
<name sortKey="Caux, Frederic" sort="Caux, Frederic" uniqKey="Caux F" first="Frederic" last="Caux">Frederic Caux</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Department of Dermatology, University of Paris XIII</s1>
<s2>Bobigny</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Marinovic, Branka" sort="Marinovic, Branka" uniqKey="Marinovic B" first="Branka" last="Marinovic">Branka Marinovic</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine</s1>
<s3>SRB</s3>
<sZ>8 aut.</sZ>
<sZ>34 aut.</sZ>
</inist:fA14>
<country>Serbie</country>
</affiliation>
</author>
<author>
<name sortKey="Sinha, Animesh A" sort="Sinha, Animesh A" uniqKey="Sinha A" first="Animesh A." last="Sinha">Animesh A. Sinha</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Department of Dermatology, State University of New York at Buffalo</s1>
<s2>Buffalo, New York</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Hertl, Michael" sort="Hertl, Michael" uniqKey="Hertl M" first="Michael" last="Hertl">Michael Hertl</name>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>Department of Dermatology, University Hospital</s1>
<s2>Marburg</s2>
<s3>ZAF</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Afrique du Sud</country>
</affiliation>
</author>
<author>
<name sortKey="Bernard, Philippe" sort="Bernard, Philippe" uniqKey="Bernard P" first="Philippe" last="Bernard">Philippe Bernard</name>
</author>
<author>
<name sortKey="Sirois, David" sort="Sirois, David" uniqKey="Sirois D" first="David" last="Sirois">David Sirois</name>
<affiliation wicri:level="1">
<inist:fA14 i1="10">
<s1>Department of Oral Medicine, New York University College of Dentistry</s1>
<s3>USA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Cianchini, Giuseppe" sort="Cianchini, Giuseppe" uniqKey="Cianchini G" first="Giuseppe" last="Cianchini">Giuseppe Cianchini</name>
<affiliation wicri:level="1">
<inist:fA14 i1="11">
<s1>Immunodermatology Departmentand</s1>
<s3>ITA</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Fairley, Janet A" sort="Fairley, Janet A" uniqKey="Fairley J" first="Janet A." last="Fairley">Janet A. Fairley</name>
<affiliation wicri:level="1">
<inist:fA14 i1="13">
<s1>Departments of Dermatology, University of Iowa and Department of Veterans Affairs Medical Center Iowa City</s1>
<s3>USA</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Jonkman, Marcel F" sort="Jonkman, Marcel F" uniqKey="Jonkman M" first="Marcel F." last="Jonkman">Marcel F. Jonkman</name>
<affiliation wicri:level="1">
<inist:fA14 i1="14">
<s1>University Medical Center Groningen, University of Groningen</s1>
<s3>DEU</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Pandya, Amit G" sort="Pandya, Amit G" uniqKey="Pandya A" first="Amit G." last="Pandya">Amit G. Pandya</name>
<affiliation wicri:level="1">
<inist:fA14 i1="15">
<s1>University of Texas Southwestern Medical Center</s1>
<s3>USA</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Rubenstein, David" sort="Rubenstein, David" uniqKey="Rubenstein D" first="David" last="Rubenstein">David Rubenstein</name>
<affiliation wicri:level="1">
<inist:fA14 i1="16">
<s1>Department of Dermatology, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>17 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>33 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Zillikens, Detlef" sort="Zillikens, Detlef" uniqKey="Zillikens D" first="Detlef" last="Zillikens">Detlef Zillikens</name>
<affiliation wicri:level="1">
<inist:fA14 i1="17">
<s1>Department of Dermatology, University of Luebeck</s1>
<s3>USA</s3>
<sZ>18 aut.</sZ>
<sZ>28 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Payne, Aimee S" sort="Payne, Aimee S" uniqKey="Payne A" first="Aimee S." last="Payne">Aimee S. Payne</name>
<affiliation wicri:level="1">
<inist:fA14 i1="19">
<s1>Department of Dermatology, University of Pennsylvania</s1>
<s3>USA</s3>
<sZ>19 aut.</sZ>
<sZ>38 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Woodley, David" sort="Woodley, David" uniqKey="Woodley D" first="David" last="Woodley">David Woodley</name>
<affiliation wicri:level="1">
<inist:fA14 i1="18">
<s1>Department of Dermatology, Keck School of Medicine, University of Southern California</s1>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Zambruno, Giovanna" sort="Zambruno, Giovanna" uniqKey="Zambruno G" first="Giovanna" last="Zambruno">Giovanna Zambruno</name>
<affiliation wicri:level="1">
<inist:fA14 i1="12">
<s1>Laboratory of Molecular and Cell Biology,Instituto Dermopatico dell'Immacolata, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) IRCCS</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>21 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Aoki, Valeria" sort="Aoki, Valeria" uniqKey="Aoki V" first="Valeria" last="Aoki">Valeria Aoki</name>
<affiliation wicri:level="1">
<inist:fA14 i1="20">
<s1>Department of Dermatology, University of Sao Paulo</s1>
<s3>USA</s3>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Pincelli, Carlo" sort="Pincelli, Carlo" uniqKey="Pincelli C" first="Carlo" last="Pincelli">Carlo Pincelli</name>
<affiliation wicri:level="1">
<inist:fA14 i1="21">
<s1>Institute of Dermatology, School of Biosciences and Biotechnologies, University of Modena and Reggio Emilia</s1>
<s3>USA</s3>
<sZ>23 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Diaz, Luis" sort="Diaz, Luis" uniqKey="Diaz L" first="Luis" last="Diaz">Luis Diaz</name>
<affiliation wicri:level="1">
<inist:fA14 i1="16">
<s1>Department of Dermatology, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>17 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>33 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Hall, Russell P" sort="Hall, Russell P" uniqKey="Hall R" first="Russell P." last="Hall">Russell P. Hall</name>
<affiliation wicri:level="1">
<inist:fA14 i1="22">
<s1>Division of Dermatology, Duke Medical Center</s1>
<s2>Durham</s2>
<s3>USA</s3>
<sZ>25 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Meurer, Michael" sort="Meurer, Michael" uniqKey="Meurer M" first="Michael" last="Meurer">Michael Meurer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="24">
<s1>Carl Gustav Carus Medical School, Dresden University of Technology"</s1>
<s3>DEU</s3>
<sZ>26 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Mascaro, Jose M Jr" sort="Mascaro, Jose M Jr" uniqKey="Mascaro J" first="Jose M. Jr" last="Mascaro">Jose M. Jr Mascaro</name>
<affiliation wicri:level="1">
<inist:fA14 i1="25">
<s1>Department of Dermatology, University of Barcelona</s1>
<s3>ESP</s3>
<sZ>27 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author>
<name sortKey="Schmidt, Enno" sort="Schmidt, Enno" uniqKey="Schmidt E" first="Enno" last="Schmidt">Enno Schmidt</name>
<affiliation wicri:level="1">
<inist:fA14 i1="17">
<s1>Department of Dermatology, University of Luebeck</s1>
<s3>USA</s3>
<sZ>18 aut.</sZ>
<sZ>28 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Shimizu, Hiroshi" sort="Shimizu, Hiroshi" uniqKey="Shimizu H" first="Hiroshi" last="Shimizu">Hiroshi Shimizu</name>
<affiliation wicri:level="1">
<inist:fA14 i1="23">
<s1>Department of Dermatology, Hokkaido University Graduate School of Medicine</s1>
<s2>Sapporo</s2>
<s3>JPN</s3>
<sZ>29 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author>
<name sortKey="Zone, John" sort="Zone, John" uniqKey="Zone J" first="John" last="Zone">John Zone</name>
</author>
<author>
<name sortKey="Swerlick, Robert" sort="Swerlick, Robert" uniqKey="Swerlick R" first="Robert" last="Swerlick">Robert Swerlick</name>
</author>
<author>
<name sortKey="Mimouni, Daniel" sort="Mimouni, Daniel" uniqKey="Mimouni D" first="Daniel" last="Mimouni">Daniel Mimouni</name>
</author>
<author>
<name sortKey="Culton, Donna" sort="Culton, Donna" uniqKey="Culton D" first="Donna" last="Culton">Donna Culton</name>
<affiliation wicri:level="1">
<inist:fA14 i1="16">
<s1>Department of Dermatology, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>17 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>33 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Lipozencic, Jasna" sort="Lipozencic, Jasna" uniqKey="Lipozencic J" first="Jasna" last="Lipozencic">Jasna Lipozencic</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine</s1>
<s3>SRB</s3>
<sZ>8 aut.</sZ>
<sZ>34 aut.</sZ>
</inist:fA14>
<country>Serbie</country>
</affiliation>
</author>
<author>
<name sortKey="Bince, Benjamin" sort="Bince, Benjamin" uniqKey="Bince B" first="Benjamin" last="Bince">Benjamin Bince</name>
</author>
<author>
<name sortKey="Grando, Sergei A" sort="Grando, Sergei A" uniqKey="Grando S" first="Sergei A." last="Grando">Sergei A. Grando</name>
</author>
<author>
<name sortKey="Bystryn, Jean Claude" sort="Bystryn, Jean Claude" uniqKey="Bystryn J" first="Jean-Claude" last="Bystryn">Jean-Claude Bystryn</name>
</author>
<author>
<name sortKey="Werth, Victoria P" sort="Werth, Victoria P" uniqKey="Werth V" first="Victoria P." last="Werth">Victoria P. Werth</name>
<affiliation wicri:level="1">
<inist:fA14 i1="19">
<s1>Department of Dermatology, University of Pennsylvania</s1>
<s3>USA</s3>
<sZ>19 aut.</sZ>
<sZ>38 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">12-0153002</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0153002 INIST</idno>
<idno type="RBID">Pascal:12-0153002</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001502</idno>
<idno type="wicri:Area/PascalFrancis/Curation">004A10</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts</title>
<author>
<name sortKey="Murrell, Dedee F" sort="Murrell, Dedee F" uniqKey="Murrell D" first="Dedee F." last="Murrell">Dedee F. Murrell</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Dermatology at St George Hospital, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Daniel, Benjamin S" sort="Daniel, Benjamin S" uniqKey="Daniel B" first="Benjamin S." last="Daniel">Benjamin S. Daniel</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Dermatology at St George Hospital, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Joly, Pascal" sort="Joly, Pascal" uniqKey="Joly P" first="Pascal" last="Joly">Pascal Joly</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Clinique Dermatologique, Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM U905, Rouen University Hospital, Dermatology Department, Rouen University Hospital, University of Rouen</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Borradori, Luca" sort="Borradori, Luca" uniqKey="Borradori L" first="Luca" last="Borradori">Luca Borradori</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Department of Dermatology, University Hospital of Bern</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Amagai, Masayuki" sort="Amagai, Masayuki" uniqKey="Amagai M" first="Masayuki" last="Amagai">Masayuki Amagai</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Keio University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author>
<name sortKey="Hashimoto, Takashi" sort="Hashimoto, Takashi" uniqKey="Hashimoto T" first="Takashi" last="Hashimoto">Takashi Hashimoto</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Kurume University School of Medicine</s1>
<s3>JPN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author>
<name sortKey="Caux, Frederic" sort="Caux, Frederic" uniqKey="Caux F" first="Frederic" last="Caux">Frederic Caux</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Department of Dermatology, University of Paris XIII</s1>
<s2>Bobigny</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Marinovic, Branka" sort="Marinovic, Branka" uniqKey="Marinovic B" first="Branka" last="Marinovic">Branka Marinovic</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine</s1>
<s3>SRB</s3>
<sZ>8 aut.</sZ>
<sZ>34 aut.</sZ>
</inist:fA14>
<country>Serbie</country>
</affiliation>
</author>
<author>
<name sortKey="Sinha, Animesh A" sort="Sinha, Animesh A" uniqKey="Sinha A" first="Animesh A." last="Sinha">Animesh A. Sinha</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Department of Dermatology, State University of New York at Buffalo</s1>
<s2>Buffalo, New York</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Hertl, Michael" sort="Hertl, Michael" uniqKey="Hertl M" first="Michael" last="Hertl">Michael Hertl</name>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>Department of Dermatology, University Hospital</s1>
<s2>Marburg</s2>
<s3>ZAF</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Afrique du Sud</country>
</affiliation>
</author>
<author>
<name sortKey="Bernard, Philippe" sort="Bernard, Philippe" uniqKey="Bernard P" first="Philippe" last="Bernard">Philippe Bernard</name>
</author>
<author>
<name sortKey="Sirois, David" sort="Sirois, David" uniqKey="Sirois D" first="David" last="Sirois">David Sirois</name>
<affiliation wicri:level="1">
<inist:fA14 i1="10">
<s1>Department of Oral Medicine, New York University College of Dentistry</s1>
<s3>USA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Cianchini, Giuseppe" sort="Cianchini, Giuseppe" uniqKey="Cianchini G" first="Giuseppe" last="Cianchini">Giuseppe Cianchini</name>
<affiliation wicri:level="1">
<inist:fA14 i1="11">
<s1>Immunodermatology Departmentand</s1>
<s3>ITA</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Fairley, Janet A" sort="Fairley, Janet A" uniqKey="Fairley J" first="Janet A." last="Fairley">Janet A. Fairley</name>
<affiliation wicri:level="1">
<inist:fA14 i1="13">
<s1>Departments of Dermatology, University of Iowa and Department of Veterans Affairs Medical Center Iowa City</s1>
<s3>USA</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Jonkman, Marcel F" sort="Jonkman, Marcel F" uniqKey="Jonkman M" first="Marcel F." last="Jonkman">Marcel F. Jonkman</name>
<affiliation wicri:level="1">
<inist:fA14 i1="14">
<s1>University Medical Center Groningen, University of Groningen</s1>
<s3>DEU</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Pandya, Amit G" sort="Pandya, Amit G" uniqKey="Pandya A" first="Amit G." last="Pandya">Amit G. Pandya</name>
<affiliation wicri:level="1">
<inist:fA14 i1="15">
<s1>University of Texas Southwestern Medical Center</s1>
<s3>USA</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Rubenstein, David" sort="Rubenstein, David" uniqKey="Rubenstein D" first="David" last="Rubenstein">David Rubenstein</name>
<affiliation wicri:level="1">
<inist:fA14 i1="16">
<s1>Department of Dermatology, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>17 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>33 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Zillikens, Detlef" sort="Zillikens, Detlef" uniqKey="Zillikens D" first="Detlef" last="Zillikens">Detlef Zillikens</name>
<affiliation wicri:level="1">
<inist:fA14 i1="17">
<s1>Department of Dermatology, University of Luebeck</s1>
<s3>USA</s3>
<sZ>18 aut.</sZ>
<sZ>28 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Payne, Aimee S" sort="Payne, Aimee S" uniqKey="Payne A" first="Aimee S." last="Payne">Aimee S. Payne</name>
<affiliation wicri:level="1">
<inist:fA14 i1="19">
<s1>Department of Dermatology, University of Pennsylvania</s1>
<s3>USA</s3>
<sZ>19 aut.</sZ>
<sZ>38 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Woodley, David" sort="Woodley, David" uniqKey="Woodley D" first="David" last="Woodley">David Woodley</name>
<affiliation wicri:level="1">
<inist:fA14 i1="18">
<s1>Department of Dermatology, Keck School of Medicine, University of Southern California</s1>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Zambruno, Giovanna" sort="Zambruno, Giovanna" uniqKey="Zambruno G" first="Giovanna" last="Zambruno">Giovanna Zambruno</name>
<affiliation wicri:level="1">
<inist:fA14 i1="12">
<s1>Laboratory of Molecular and Cell Biology,Instituto Dermopatico dell'Immacolata, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) IRCCS</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>21 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Aoki, Valeria" sort="Aoki, Valeria" uniqKey="Aoki V" first="Valeria" last="Aoki">Valeria Aoki</name>
<affiliation wicri:level="1">
<inist:fA14 i1="20">
<s1>Department of Dermatology, University of Sao Paulo</s1>
<s3>USA</s3>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Pincelli, Carlo" sort="Pincelli, Carlo" uniqKey="Pincelli C" first="Carlo" last="Pincelli">Carlo Pincelli</name>
<affiliation wicri:level="1">
<inist:fA14 i1="21">
<s1>Institute of Dermatology, School of Biosciences and Biotechnologies, University of Modena and Reggio Emilia</s1>
<s3>USA</s3>
<sZ>23 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Diaz, Luis" sort="Diaz, Luis" uniqKey="Diaz L" first="Luis" last="Diaz">Luis Diaz</name>
<affiliation wicri:level="1">
<inist:fA14 i1="16">
<s1>Department of Dermatology, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>17 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>33 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Hall, Russell P" sort="Hall, Russell P" uniqKey="Hall R" first="Russell P." last="Hall">Russell P. Hall</name>
<affiliation wicri:level="1">
<inist:fA14 i1="22">
<s1>Division of Dermatology, Duke Medical Center</s1>
<s2>Durham</s2>
<s3>USA</s3>
<sZ>25 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Meurer, Michael" sort="Meurer, Michael" uniqKey="Meurer M" first="Michael" last="Meurer">Michael Meurer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="24">
<s1>Carl Gustav Carus Medical School, Dresden University of Technology"</s1>
<s3>DEU</s3>
<sZ>26 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Mascaro, Jose M Jr" sort="Mascaro, Jose M Jr" uniqKey="Mascaro J" first="Jose M. Jr" last="Mascaro">Jose M. Jr Mascaro</name>
<affiliation wicri:level="1">
<inist:fA14 i1="25">
<s1>Department of Dermatology, University of Barcelona</s1>
<s3>ESP</s3>
<sZ>27 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author>
<name sortKey="Schmidt, Enno" sort="Schmidt, Enno" uniqKey="Schmidt E" first="Enno" last="Schmidt">Enno Schmidt</name>
<affiliation wicri:level="1">
<inist:fA14 i1="17">
<s1>Department of Dermatology, University of Luebeck</s1>
<s3>USA</s3>
<sZ>18 aut.</sZ>
<sZ>28 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Shimizu, Hiroshi" sort="Shimizu, Hiroshi" uniqKey="Shimizu H" first="Hiroshi" last="Shimizu">Hiroshi Shimizu</name>
<affiliation wicri:level="1">
<inist:fA14 i1="23">
<s1>Department of Dermatology, Hokkaido University Graduate School of Medicine</s1>
<s2>Sapporo</s2>
<s3>JPN</s3>
<sZ>29 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author>
<name sortKey="Zone, John" sort="Zone, John" uniqKey="Zone J" first="John" last="Zone">John Zone</name>
</author>
<author>
<name sortKey="Swerlick, Robert" sort="Swerlick, Robert" uniqKey="Swerlick R" first="Robert" last="Swerlick">Robert Swerlick</name>
</author>
<author>
<name sortKey="Mimouni, Daniel" sort="Mimouni, Daniel" uniqKey="Mimouni D" first="Daniel" last="Mimouni">Daniel Mimouni</name>
</author>
<author>
<name sortKey="Culton, Donna" sort="Culton, Donna" uniqKey="Culton D" first="Donna" last="Culton">Donna Culton</name>
<affiliation wicri:level="1">
<inist:fA14 i1="16">
<s1>Department of Dermatology, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>17 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>33 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Lipozencic, Jasna" sort="Lipozencic, Jasna" uniqKey="Lipozencic J" first="Jasna" last="Lipozencic">Jasna Lipozencic</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine</s1>
<s3>SRB</s3>
<sZ>8 aut.</sZ>
<sZ>34 aut.</sZ>
</inist:fA14>
<country>Serbie</country>
</affiliation>
</author>
<author>
<name sortKey="Bince, Benjamin" sort="Bince, Benjamin" uniqKey="Bince B" first="Benjamin" last="Bince">Benjamin Bince</name>
</author>
<author>
<name sortKey="Grando, Sergei A" sort="Grando, Sergei A" uniqKey="Grando S" first="Sergei A." last="Grando">Sergei A. Grando</name>
</author>
<author>
<name sortKey="Bystryn, Jean Claude" sort="Bystryn, Jean Claude" uniqKey="Bystryn J" first="Jean-Claude" last="Bystryn">Jean-Claude Bystryn</name>
</author>
<author>
<name sortKey="Werth, Victoria P" sort="Werth, Victoria P" uniqKey="Werth V" first="Victoria P." last="Werth">Victoria P. Werth</name>
<affiliation wicri:level="1">
<inist:fA14 i1="19">
<s1>Department of Dermatology, University of Pennsylvania</s1>
<s3>USA</s3>
<sZ>19 aut.</sZ>
<sZ>38 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of the American Academy of Dermatology</title>
<title level="j" type="abbreviated">J. Am. Acad. Dermatol.</title>
<idno type="ISSN">0190-9622</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of the American Academy of Dermatology</title>
<title level="j" type="abbreviated">J. Am. Acad. Dermatol.</title>
<idno type="ISSN">0190-9622</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Bullous pemphigoid</term>
<term>Definition</term>
<term>Dermatology</term>
<term>Prognosis</term>
<term>Recommendation</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Pemphigoïde bulleuse</term>
<term>Définition</term>
<term>Pronostic</term>
<term>Recommandation</term>
<term>Dermatologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Recommandation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0190-9622</s0>
</fA01>
<fA02 i1="01">
<s0>JAADDB</s0>
</fA02>
<fA03 i2="1">
<s0>J. Am. Acad. Dermatol.</s0>
</fA03>
<fA05>
<s2>66</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>MURRELL (Dedee F.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>DANIEL (Benjamin S.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>JOLY (Pascal)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>BORRADORI (Luca)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>AMAGAI (Masayuki)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>HASHIMOTO (Takashi)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>CAUX (Frederic)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>MARINOVIC (Branka)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>SINHA (Animesh A.)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>HERTL (Michael)</s1>
</fA11>
<fA11 i1="11" i2="1">
<s1>BERNARD (Philippe)</s1>
</fA11>
<fA11 i1="12" i2="1">
<s1>SIROIS (David)</s1>
</fA11>
<fA11 i1="13" i2="1">
<s1>CIANCHINI (Giuseppe)</s1>
</fA11>
<fA11 i1="14" i2="1">
<s1>FAIRLEY (Janet A.)</s1>
</fA11>
<fA11 i1="15" i2="1">
<s1>JONKMAN (Marcel F.)</s1>
</fA11>
<fA11 i1="16" i2="1">
<s1>PANDYA (Amit G.)</s1>
</fA11>
<fA11 i1="17" i2="1">
<s1>RUBENSTEIN (David)</s1>
</fA11>
<fA11 i1="18" i2="1">
<s1>ZILLIKENS (Detlef)</s1>
</fA11>
<fA11 i1="19" i2="1">
<s1>PAYNE (Aimee S.)</s1>
</fA11>
<fA11 i1="20" i2="1">
<s1>WOODLEY (David)</s1>
</fA11>
<fA11 i1="21" i2="1">
<s1>ZAMBRUNO (Giovanna)</s1>
</fA11>
<fA11 i1="22" i2="1">
<s1>AOKI (Valeria)</s1>
</fA11>
<fA11 i1="23" i2="1">
<s1>PINCELLI (Carlo)</s1>
</fA11>
<fA11 i1="24" i2="1">
<s1>DIAZ (Luis)</s1>
</fA11>
<fA11 i1="25" i2="1">
<s1>HALL (Russell P.)</s1>
</fA11>
<fA11 i1="26" i2="1">
<s1>MEURER (Michael)</s1>
</fA11>
<fA11 i1="27" i2="1">
<s1>MASCARO (Jose M. JR)</s1>
</fA11>
<fA11 i1="28" i2="1">
<s1>SCHMIDT (Enno)</s1>
</fA11>
<fA11 i1="29" i2="1">
<s1>SHIMIZU (Hiroshi)</s1>
</fA11>
<fA11 i1="30" i2="1">
<s1>ZONE (John)</s1>
</fA11>
<fA11 i1="31" i2="1">
<s1>SWERLICK (Robert)</s1>
</fA11>
<fA11 i1="32" i2="1">
<s1>MIMOUNI (Daniel)</s1>
</fA11>
<fA11 i1="33" i2="1">
<s1>CULTON (Donna)</s1>
</fA11>
<fA11 i1="34" i2="1">
<s1>LIPOZENCIC (Jasna)</s1>
</fA11>
<fA11 i1="35" i2="1">
<s1>BINCE (Benjamin)</s1>
</fA11>
<fA11 i1="36" i2="1">
<s1>GRANDO (Sergei A.)</s1>
</fA11>
<fA11 i1="37" i2="1">
<s1>BYSTRYN (Jean-Claude)</s1>
</fA11>
<fA11 i1="38" i2="1">
<s1>WERTH (Victoria P.)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Dermatology at St George Hospital, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Clinique Dermatologique, Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM U905, Rouen University Hospital, Dermatology Department, Rouen University Hospital, University of Rouen</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Department of Dermatology, University Hospital of Bern</s1>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Keio University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Kurume University School of Medicine</s1>
<s3>JPN</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Department of Dermatology, University of Paris XIII</s1>
<s2>Bobigny</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="07">
<s1>Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine</s1>
<s3>SRB</s3>
<sZ>8 aut.</sZ>
<sZ>34 aut.</sZ>
</fA14>
<fA14 i1="08">
<s1>Department of Dermatology, State University of New York at Buffalo</s1>
<s2>Buffalo, New York</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="09">
<s1>Department of Dermatology, University Hospital</s1>
<s2>Marburg</s2>
<s3>ZAF</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="10">
<s1>Department of Oral Medicine, New York University College of Dentistry</s1>
<s3>USA</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="11">
<s1>Immunodermatology Departmentand</s1>
<s3>ITA</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="12">
<s1>Laboratory of Molecular and Cell Biology,Instituto Dermopatico dell'Immacolata, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) IRCCS</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>21 aut.</sZ>
</fA14>
<fA14 i1="13">
<s1>Departments of Dermatology, University of Iowa and Department of Veterans Affairs Medical Center Iowa City</s1>
<s3>USA</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="14">
<s1>University Medical Center Groningen, University of Groningen</s1>
<s3>DEU</s3>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="15">
<s1>University of Texas Southwestern Medical Center</s1>
<s3>USA</s3>
<sZ>16 aut.</sZ>
</fA14>
<fA14 i1="16">
<s1>Department of Dermatology, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>17 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>33 aut.</sZ>
</fA14>
<fA14 i1="17">
<s1>Department of Dermatology, University of Luebeck</s1>
<s3>USA</s3>
<sZ>18 aut.</sZ>
<sZ>28 aut.</sZ>
</fA14>
<fA14 i1="18">
<s1>Department of Dermatology, Keck School of Medicine, University of Southern California</s1>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</fA14>
<fA14 i1="19">
<s1>Department of Dermatology, University of Pennsylvania</s1>
<s3>USA</s3>
<sZ>19 aut.</sZ>
<sZ>38 aut.</sZ>
</fA14>
<fA14 i1="20">
<s1>Department of Dermatology, University of Sao Paulo</s1>
<s3>USA</s3>
<sZ>22 aut.</sZ>
</fA14>
<fA14 i1="21">
<s1>Institute of Dermatology, School of Biosciences and Biotechnologies, University of Modena and Reggio Emilia</s1>
<s3>USA</s3>
<sZ>23 aut.</sZ>
</fA14>
<fA14 i1="22">
<s1>Division of Dermatology, Duke Medical Center</s1>
<s2>Durham</s2>
<s3>USA</s3>
<sZ>25 aut.</sZ>
</fA14>
<fA14 i1="23">
<s1>Department of Dermatology, Hokkaido University Graduate School of Medicine</s1>
<s2>Sapporo</s2>
<s3>JPN</s3>
<sZ>29 aut.</sZ>
</fA14>
<fA14 i1="24">
<s1>Carl Gustav Carus Medical School, Dresden University of Technology"</s1>
<s3>DEU</s3>
<sZ>26 aut.</sZ>
</fA14>
<fA14 i1="25">
<s1>Department of Dermatology, University of Barcelona</s1>
<s3>ESP</s3>
<sZ>27 aut.</sZ>
</fA14>
<fA20>
<s1>479-485</s1>
</fA20>
<fA21>
<s1>2012</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>18387</s2>
<s5>354000502871510180</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>10 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>12-0153002</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Journal of the American Academy of Dermatology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B08E</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Pemphigoïde bulleuse</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Bullous pemphigoid</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Penfigoide buloso</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Définition</s0>
<s5>07</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Definition</s0>
<s5>07</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Definición</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Pronostic</s0>
<s5>08</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Prognosis</s0>
<s5>08</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Pronóstico</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Recommandation</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Recommendation</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Recomendación</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Dermatologie</s0>
<s5>13</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Dermatology</s0>
<s5>13</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Dermatología</s0>
<s5>13</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Dermatose bulleuse</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Bullous dermatosis</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Dermatosis bulosa</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Maladie autoimmune</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Autoimmune disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Enfermedad autoinmune</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Pathologie de la peau</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Skin disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Piel patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Immunopathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Immunopathology</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Inmunopatología</s0>
<s5>40</s5>
</fC07>
<fN21>
<s1>114</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004A10 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 004A10 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:12-0153002
   |texte=   Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024